- Home
- NBY vs BHB Comparison
NBY vs BHB Comparison
Compare NBY & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- BHB
- Stock Information
- Founded
- NBY 2000
- BHB 1887
- Country
- NBY United States
- BHB United States
- Employees
- NBY N/A
- BHB N/A
- Industry
- NBY
- BHB Major Banks
- Sector
- NBY
- BHB Finance
- Exchange
- NBY Nasdaq
- BHB Nasdaq
- Market Cap
- NBY 3.5M
- BHB N/A
- IPO Year
- NBY 2007
- BHB 1997
- Fundamental
- Price
- NBY $0.63
- BHB $30.13
- Analyst Decision
- NBY
- BHB Hold
- Analyst Count
- NBY 0
- BHB 2
- Target Price
- NBY N/A
- BHB $30.50
- AVG Volume (30 Days)
- NBY 7.7M
- BHB 36.0K
- Earning Date
- NBY 11-07-2024
- BHB 10-22-2024
- Dividend Yield
- NBY N/A
- BHB 3.99%
- EPS Growth
- NBY N/A
- BHB N/A
- EPS
- NBY N/A
- BHB 2.71
- Revenue
- NBY $13,884,000.00
- BHB $147,425,000.00
- Revenue This Year
- NBY N/A
- BHB N/A
- Revenue Next Year
- NBY $26.04
- BHB $4.34
- P/E Ratio
- NBY N/A
- BHB $11.09
- Revenue Growth
- NBY 4.06
- BHB N/A
- 52 Week Low
- NBY $0.07
- BHB $23.18
- 52 Week High
- NBY $6.30
- BHB $33.31
- Technical
- Relative Strength Index (RSI)
- NBY 44.88
- BHB 50.99
- Support Level
- NBY $0.64
- BHB $28.73
- Resistance Level
- NBY $0.70
- BHB $29.66
- Average True Range (ATR)
- NBY 0.05
- BHB 0.74
- MACD
- NBY -0.00
- BHB -0.07
- Stochastic Oscillator
- NBY 0.00
- BHB 67.42
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.